Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 652.35
+9.55 (1.49%)
Jan 7, 2026, 11:50 AM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 361 billion as of January 6, 2026.
Market Cap
361.00B
Enterprise Value
351.79B
Revenue
20.77B
Ranking
n/a
PE Ratio
69.77
Stock Price
652.35
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has decreased from 410.17B to 361.00B, a decrease of -11.99%. That is a compound annual growth rate of -24.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 361.00B | -1.34% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.70T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 922.62B |
| Mankind Pharma | 909.29B |
| Aurobindo Pharma | 705.91B |
| Fortis Healthcare | 690.60B |